+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vacutainer Mononuclear Cell Preparation Tube Market by Application (Academic Research, Biopharmaceutical Research, Clinical Research), End User (Contract Research Organizations, Diagnostic Laboratories, Hospitals), Product Type, Distribution Channel - Global Forecast 2025-2030- Product Image
Vacutainer Mononuclear Cell Preparation Tube Market by Application (Academic Research, Biopharmaceutical Research, Clinical Research), End User (Contract Research Organizations, Diagnostic Laboratories, Hospitals), Product Type, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Vacutainer Mononuclear Cell Preparation Tube Market by Application (Academic Research, Biopharmaceutical Research, Clinical Research), End User (Contract Research Organizations, Diagnostic Laboratories, Hospitals), Product Type, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6136946
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Mononuclear cell preparation tubes have emerged as indispensable tools in modern cellular research, enabling the rapid and reliable isolation of peripheral blood mononuclear cells for downstream analyses. Their design incorporates density gradient media and specialized separation barriers, offering a standardized approach that reduces operator variability and preserves cell functionality under stringent laboratory conditions.

In recent years, these preparation tubes have become foundational across both academic and applied research environments. Researchers engaged in basic science and translational studies depend on consistent cell recovery to validate immunological assays, while biopharmaceutical teams focus on cell therapy development and drug discovery pipelines that require high-purity mononuclear populations. As personalized medicine initiatives intensify, these tubes will play a pivotal role in bolstering reproducibility, maintaining regulatory compliance, and driving innovation across clinical research workflows

Transformative Advances Redefining Mononuclear Cell Separation Technologies Through Automation Integration and Disposable Innovations for Enhanced Precision

The landscape of mononuclear cell separation has shifted dramatically with the integration of automation and single-use innovations. Automated systems now couple with these tubes to streamline sample handling, minimize manual errors, and accelerate throughput. At the same time, disposable tube formats have gained traction, offering enhanced sterility assurances and reducing cross-contamination risks in multi-user laboratories.

Meanwhile, advanced barrier materials and pre-loaded gradient media have improved separation precision, leading to higher cell viability and more reproducible yields. Digital tracking systems now link tube barcodes to laboratory information management platforms, enabling real-time process monitoring and data integrity across decentralized research sites. As these transformative shifts converge, they are redefining workflow efficiency, strengthening quality control, and unlocking new avenues for cellular therapy research

Assessing the Comprehensive Effects of United States Tariff Measures in 2025 on Supply Chains Procurement Costs and Operational Strategies

The introduction of new tariff measures by the United States in 2025 has prompted critical adjustments across supply chains for reagents and specialized plastics used in mononuclear cell preparation tubes. Manufacturers have responded by diversifying sourcing strategies, negotiating alternative logistics routes, and exploring regional manufacturing hubs to mitigate cost pressures. Consequently, procurement teams now integrate tariff scenario planning into annual budgeting cycles to safeguard against sudden cost escalations.

In parallel, strategic partnerships with domestic suppliers of additives such as EDTA and heparin have emerged to enhance supply security. This shift supports compliance with trade regulations while preserving the quality of separation media. Ultimately, companies that proactively addressed tariff impacts have maintained stable production schedules, preserved pricing competitiveness, and strengthened resilience against future trade uncertainties

Uncovering Strategic Market Segmentation Insights Spanning Diverse Applications End Users Product Types and Distribution Channels Driving Targeted Adoption

Within academic research environments, both basic science and translational research groups rely on tailored mononuclear cell preparation tubes that ensure uniform gradient separation. Biopharmaceutical researchers focused on cell therapy development and drug discovery have prioritized tubes with specialized additives to maximize cell viability. In clinical research settings, investigators in immunology, neurology, and oncology demand consistent cell yields to support biomarker assays and personalized treatment evaluations.

Contract research organizations at a global and regional scale have centralized procurement to streamline distribution and maintain consistent quality across multiple trial sites. Diagnostic laboratories, spanning hospital and reference facilities, have standardized tube usage to enhance workflow efficiency. Hospitals-both private and public-have integrated these tubes into point-of-care workflows, and research institutes within government and university laboratories continue to leverage them for high-throughput studies.

Product portfolios now feature EDTA-based tubes with K2 and K3 formulations alongside lithium and sodium heparin options to cater to diverse assay requirements. Volumes range from micro-volume configurations designed for rare sample collections to standard volumes suited for large-scale processing. Direct sales channels facilitate direct engagement with manufacturers, national and regional distributors extend availability across multiple geographies, and online platforms-including dedicated websites and third-party e-commerce sites-offer flexible ordering and rapid fulfillment

Revealing Regional Dynamics and Growth Drivers Shaping the Vacutainer Mononuclear Cell Preparation Tube Market Across Americas EMEA and Asia Pacific

In the Americas, strong investments in research infrastructure and a robust clinical trial ecosystem have underpinned widespread adoption of mononuclear cell preparation tubes. Laboratories in North America benefit from established logistics networks that support timely delivery of reagents and specialized disposables. At the same time, Latin American centers are expanding capacity through partnerships with local distribution partners, driving accessibility to advanced separation technologies.

Across Europe, the Middle East, and Africa, regulatory harmonization initiatives and growing biopharma hubs in Western Europe have created fertile ground for tube manufacturers to expand their footprint. Emerging markets in the Middle East and North Africa are investing in diagnostic laboratory upgrades, fueling demand for reliable cell separation solutions. Simultaneously, sub-Saharan research institutions are forging collaborations with global suppliers to enhance local capabilities.

In Asia-Pacific, rapid growth in clinical research and burgeoning cell therapy development have made countries such as China, Japan, and South Korea focal points for innovation. Regional distributors are forming strategic alliances with manufacturers to meet surging demand, while online procurement channels are gaining popularity in remote locations. Collectively, these regional dynamics are shaping differentiated growth trajectories and revealing targeted opportunities for market expansion

Examining Leading Industry Players Strategies Partnerships and Innovations Driving Competitive Advantage in the Mononuclear Cell Preparation Tube Sector

Leading manufacturers have focused on expanding their product portfolios through strategic collaborations and targeted acquisitions. Some global corporations have invested in R&D partnerships with academic centers to develop next-generation gradient media that enhance cell purity. Others have established pilot production facilities in key regions to address local regulatory requirements and reduce lead times.

In parallel, several industry players have enhanced customer support through digital platforms offering protocol optimization tools and virtual training modules. By forging alliances with specialty reagent suppliers, select companies have secured exclusive access to innovative additives, thereby differentiating their tube offerings. Meanwhile, niche vendors are carving out market share by catering to specialized applications, such as immunotherapy cell expansion and neuroinflammation assays, delivering tailored separation solutions to meet specific research needs

Strategic Recommendations for Industry Leaders to Enhance Operational Efficiency Innovation and Market Position in Mononuclear Cell Preparation Solutions

Industry leaders should prioritize automation compatibility by collaborating with instrument manufacturers to develop integrated workflows that reduce hands-on time and improve reproducibility. Investing in the development of novel gradient media formulations will address emerging application demands, especially within cell therapy and personalized immunology research. Additionally, strengthening regional manufacturing and distribution networks can mitigate tariff risks and accelerate delivery timelines.

To enhance market reach, organizations should bolster their digital engagement strategies by improving online ordering portals and offering real-time inventory visibility. Cultivating partnerships with contract research organizations and diagnostic laboratories will foster long-term procurement agreements, ensuring stable demand pipelines. Finally, adopting a consultative sales approach that highlights application-specific benefits will differentiate offerings and drive deeper customer relationships

Methodological Framework Outlining Research Design Data Collection Analytical Techniques and Validation Approaches for Mononuclear Cell Preparation Tube Study

This study employed a structured research framework combining secondary and primary data collection methods. Initially, comprehensive literature reviews of peer-reviewed journals, regulatory filings, and public company disclosures established foundational knowledge of mononuclear cell separation technologies. Secondary insights were then validated through in-depth interviews with laboratory directors, procurement specialists, and product managers across key end-user segments.

Quantitative data were triangulated using multiple sources to ensure accuracy and consistency. Analytical techniques, including SWOT and PESTEL analyses, provided a holistic view of market drivers, challenges, and regulatory influences. Validation processes incorporated cross-referencing supplier shipment records and trade data to capture tariff impacts accurately. Finally, a multi-layered internal review ensured methodological rigor and alignment with industry best practices

Concluding Perspectives on the Evolving Role of Vacutainer Mononuclear Cell Preparation Tubes in Catalyzing Innovations and Clinical Research Breakthroughs

Throughout this analysis, mononuclear cell preparation tubes have been shown to play an essential role in supporting diverse research workflows and clinical investigations. Ongoing shifts toward automation, disposable designs, and digital integration are reshaping the technology landscape, while evolving tariff environments have driven strategic supply chain adaptations. Detailed segmentation insights illuminate how application areas, end-user types, product variants, and distribution channels contribute to differentiated adoption patterns across regions.

Looking ahead, manufacturers that embrace innovation in gradient media, expand their regional presence, and drive consultative partnerships will be best positioned to respond to the complex needs of research and clinical stakeholders. By aligning product development with emerging scientific trends and operational exigencies, the mononuclear cell preparation tube sector is poised to deliver continued value and enable the next wave of breakthroughs in cellular research

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Academic Research
      • Basic Science
      • Translational Research
    • Biopharmaceutical Research
      • Cell Therapy Development
      • Drug Discovery
    • Clinical Research
      • Immunology
      • Neurology
      • Oncology
  • End User
    • Contract Research Organizations
      • Global CROS
      • Regional CROS
    • Diagnostic Laboratories
      • Hospital Laboratories
      • Reference Laboratories
    • Hospitals
      • Private Hospitals
      • Public Hospitals
    • Research Institutes
      • Government Institutes
      • University Laboratories
  • Product Type
    • Additive Composition
      • Edta Type
        • K2 Edta
        • K3 Edta
      • Heparin Type
        • Lithium Heparin
        • Sodium Heparin
    • Tube Volume
      • Micro Volume
      • Standard Volume
  • Distribution Channel
    • Direct Sales
    • Distributors
      • National Distributors
      • Regional Distributors
    • Online Sales
      • Manufacturer Website
      • Third-Party E-Commerce
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Greiner Bio-One International GmbH
  • STEMCELL Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Sarstedt AG & Co. KG
  • Miltenyi Biotec GmbH
  • Corning Incorporated
  • Terumo Corporation
  • Merck KGaA

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growth in demand for prefilled Ficoll-based vacutainer tubes for standardized PBMC isolation in immuno-oncology research
5.2. Integration of barrier-based mononuclear cell separation technology in vacutainer tubes to enhance cell viability and purity
5.3. Rising adoption of automated robotic platforms compatible with vacutainer mononuclear cell tubes for high-throughput sample processing
5.4. Regulatory focus on GMP-compliant vacutainer mononuclear cell preparation tubes to support clinical cell therapy manufacturing
5.5. Expansion of point-of-care mononuclear cell isolation using vacutainer tubes to enable rapid immunophenotyping in remote clinics
5.6. Collaborations between tube manufacturers and CROs offering end-to-end PBMC collection and analysis solutions with vacutainer systems
5.7. Surge in single-cell sequencing applications driving demand for high-purity mononuclear cell isolation tubes with minimal contaminant levels
5.8. Development of temperature-controlled vacutainer mononuclear cell tubes to maintain cell integrity during transport and storage
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vacutainer Mononuclear Cell Preparation Tube Market, by Application
8.1. Introduction
8.2. Academic Research
8.2.1. Basic Science
8.2.2. Translational Research
8.3. Biopharmaceutical Research
8.3.1. Cell Therapy Development
8.3.2. Drug Discovery
8.4. Clinical Research
8.4.1. Immunology
8.4.2. Neurology
8.4.3. Oncology
9. Vacutainer Mononuclear Cell Preparation Tube Market, by End User
9.1. Introduction
9.2. Contract Research Organizations
9.2.1. Global CROS
9.2.2. Regional CROS
9.3. Diagnostic Laboratories
9.3.1. Hospital Laboratories
9.3.2. Reference Laboratories
9.4. Hospitals
9.4.1. Private Hospitals
9.4.2. Public Hospitals
9.5. Research Institutes
9.5.1. Government Institutes
9.5.2. University Laboratories
10. Vacutainer Mononuclear Cell Preparation Tube Market, by Product Type
10.1. Introduction
10.2. Additive Composition
10.2.1. Edta Type
10.2.1.1. K2 Edta
10.2.1.2. K3 Edta
10.2.2. Heparin Type
10.2.2.1. Lithium Heparin
10.2.2.2. Sodium Heparin
10.3. Tube Volume
10.3.1. Micro Volume
10.3.2. Standard Volume
11. Vacutainer Mononuclear Cell Preparation Tube Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.3.1. National Distributors
11.3.2. Regional Distributors
11.4. Online Sales
11.4.1. Manufacturer Website
11.4.2. Third-Party E-Commerce
12. Americas Vacutainer Mononuclear Cell Preparation Tube Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Vacutainer Mononuclear Cell Preparation Tube Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Vacutainer Mononuclear Cell Preparation Tube Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Becton, Dickinson and Company
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Greiner Bio-One International GmbH
15.3.4. STEMCELL Technologies Inc.
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Sarstedt AG & Co. KG
15.3.7. Miltenyi Biotec GmbH
15.3.8. Corning Incorporated
15.3.9. Terumo Corporation
15.3.10. Merck KGaA
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET: RESEARCHAI
FIGURE 24. VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET: RESEARCHSTATISTICS
FIGURE 25. VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET: RESEARCHCONTACTS
FIGURE 26. VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BASIC SCIENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BASIC SCIENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BIOPHARMACEUTICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BIOPHARMACEUTICAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CELL THERAPY DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CELL THERAPY DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BIOPHARMACEUTICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BIOPHARMACEUTICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CLINICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY GLOBAL CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY GLOBAL CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY REGIONAL CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY REGIONAL CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY UNIVERSITY LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ADDITIVE COMPOSITION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ADDITIVE COMPOSITION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY EDTA TYPE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY EDTA TYPE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY K2 EDTA, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY K2 EDTA, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY K3 EDTA, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY K3 EDTA, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY EDTA TYPE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY EDTA TYPE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HEPARIN TYPE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HEPARIN TYPE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY LITHIUM HEPARIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY LITHIUM HEPARIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY SODIUM HEPARIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY SODIUM HEPARIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HEPARIN TYPE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HEPARIN TYPE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ADDITIVE COMPOSITION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ADDITIVE COMPOSITION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TUBE VOLUME, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TUBE VOLUME, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY MICRO VOLUME, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY MICRO VOLUME, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY STANDARD VOLUME, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY STANDARD VOLUME, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TUBE VOLUME, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TUBE VOLUME, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY THIRD-PARTY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BIOPHARMACEUTICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BIOPHARMACEUTICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CLINICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ADDITIVE COMPOSITION, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ADDITIVE COMPOSITION, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY EDTA TYPE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY EDTA TYPE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HEPARIN TYPE, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HEPARIN TYPE, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TUBE VOLUME, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TUBE VOLUME, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BIOPHARMACEUTICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BIOPHARMACEUTICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CLINICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ADDITIVE COMPOSITION, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ADDITIVE COMPOSITION, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY EDTA TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY EDTA TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HEPARIN TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HEPARIN TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TUBE VOLUME, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TUBE VOLUME, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 193. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 196. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 197. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BIOPHARMACEUTICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 198. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BIOPHARMACEUTICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 199. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 200. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CLINICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 201. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 204. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 205. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 206. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 207. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 208. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 209. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 210. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 211. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ADDITIVE COMPOSITION, 2018-2024 (USD MILLION)
TABLE 214. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ADDITIVE COMPOSITION, 2025-2030 (USD MILLION)
TABLE 215. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY EDTA TYPE, 2018-2024 (USD MILLION)
TABLE 216. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY EDTA TYPE, 2025-2030 (USD MILLION)
TABLE 217. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HEPARIN TYPE, 2018-2024 (USD MILLION)
TABLE 218. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HEPARIN TYPE, 2025-2030 (USD MILLION)
TABLE 219. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TUBE VOLUME, 2018-2024 (USD MILLION)
TABLE 220. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TUBE VOLUME, 2025-2030 (USD MILLION)
TABLE 221. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 224. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 225. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 226. CANADA VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 227. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 230. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 231. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BIOPHARMACEUTICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 232. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY BIOPHARMACEUTICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 233. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CLINICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 234. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CLINICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 235. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 239. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 240. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 241. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 242. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 243. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 244. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 245. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ADDITIVE COMPOSITION, 2018-2024 (USD MILLION)
TABLE 248. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ADDITIVE COMPOSITION, 2025-2030 (USD MILLION)
TABLE 249. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY EDTA TYPE, 2018-2024 (USD MILLION)
TABLE 250. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY EDTA TYPE, 2025-2030 (USD MILLION)
TABLE 251. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HEPARIN TYPE, 2018-2024 (USD MILLION)
TABLE 252. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY HEPARIN TYPE, 2025-2030 (USD MILLION)
TABLE 253. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TUBE VOLUME, 2018-2024 (USD MILLION)
TABLE 254. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY TUBE VOLUME, 2025-2030 (USD MILLION)
TABLE 255. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 259. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 260. MEXICO VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL VACUTAINER MONONUCLEAR CELL PREPARATION TUBE MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Vacutainer Mononuclear Cell Preparation Tube market report include:
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Greiner Bio-One International GmbH
  • STEMCELL Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Sarstedt AG & Co. KG
  • Miltenyi Biotec GmbH
  • Corning Incorporated
  • Terumo Corporation
  • Merck KGaA

Related Reports

Vacutainer Cell Preparation Tubes Market by Application (Clinical Diagnostics, Forensic Testing, Pharmaceutical Manufacturing), End User (Clinical Laboratories, Hospitals, Pharmaceutical Companies), Product Type, Distribution Channel, Material - Global Forecast 2025-2030 - Product Image

Vacutainer Cell Preparation Tubes Market by Application (Clinical Diagnostics, Forensic Testing, Pharmaceutical Manufacturing), End User (Clinical Laboratories, Hospitals, Pharmaceutical Companies), Product Type, Distribution Channel, Material - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Vacutainer Blood Collection Tube Market by Product Type (Glass, Plastic), Blood Collection System (Butterfly, Syringe, Vacuum Tube), Additive, Application, End User, Volume - Global Forecast 2025-2030 - Product Image

Vacutainer Blood Collection Tube Market by Product Type (Glass, Plastic), Blood Collection System (Butterfly, Syringe, Vacuum Tube), Additive, Application, End User, Volume - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Blood Collection Market 2025-2029 - Product Image

Blood Collection Market 2025-2029

  • Report
  • 206 Pages
  • Global
From
Peripheral Blood Lymphocyte Separation Medium Market by Product Type (Ficoll Medium, Percoll Medium), Application (Clinical, Diagnostic, Research), End User, Cell Type - Global Forecast 2025-2030 - Product Image

Peripheral Blood Lymphocyte Separation Medium Market by Product Type (Ficoll Medium, Percoll Medium), Application (Clinical, Diagnostic, Research), End User, Cell Type - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Peripheral Blood Mononuclear Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Application, By Techniques, By Source, By Region, Competition, Forecast and Opportunities - Product Image

Peripheral Blood Mononuclear Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Application, By Techniques, By Source, By Region, Competition, Forecast and Opportunities

  • Report
  • 589 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.